» Articles » PMID: 21590464

Prevention of Type 2 Diabetes and Its Complications in Developing Countries: a Review

Overview
Journal Int J Behav Med
Publisher Informa Healthcare
Date 2011 May 19
PMID 21590464
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Type 2 diabetes mellitus (T2DM) is a significant global public health problem affecting more than 285 million people worldwide. Over 70% of those with T2DM live in developing countries, and this proportion is increasing annually. Evidence suggests that lifestyle and other nonpharmacological interventions can delay and even prevent the development of T2DM and its complications; however, to date, programs that have been specifically adapted to the needs and circumstances of developing countries have not been well developed or evaluated.

Purpose: The purpose of this article is to review published studies that evaluate lifestyle and other non-pharmacological interventions aimed at preventing T2DM and its complications in developing countries.

Methods: We undertook an electronic search of MEDLINE, PubMed, and EMBASE with the English language restriction and published until 30 September 2009.

Results: Nine relevant publications from seven studies were identified. The reported interventions predominantly used counseling and educational methods to improve diet and physical activity levels. Each intervention was found to be effective in reducing the risk of developing T2DM in people with impaired glucose tolerance, and improving glycemic control in people with T2DM.

Conclusions: The current evidence concerning the prevention of T2DM and its complications in developing countries has shown reasonably consistent and positive results; however, the small number of studies creates some significant limitations. More research is needed to evaluate the benefits of low-cost screening tools, as well as the efficacy, cost-effectiveness, and sustainability of culturally appropriate interventions in such countries.

Citing Articles

Effects of Dietary Fiber Interventions on Glycemic Control and Weight Management in Diabetes: A Systematic Review of Randomized Controlled Trials.

Abdi S, Abdi S, Ali M, Balani N, Balani N, Jacob H Cureus. 2025; 17(2):e78497.

PMID: 40051945 PMC: 11884502. DOI: 10.7759/cureus.78497.


Type 2 diabetes attributable to ambient particulate matter pollution: a global burden study from 1990 to 2019.

Sha Y, Wang S Front Public Health. 2024; 12:1371253.

PMID: 38832227 PMC: 11144887. DOI: 10.3389/fpubh.2024.1371253.


Effect of passive smoking exposure on risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies.

Qin G, Chen L, Zheng J, Wu X, Li Y, Yang K Front Endocrinol (Lausanne). 2023; 14:1195354.

PMID: 37600719 PMC: 10432686. DOI: 10.3389/fendo.2023.1195354.


Strains of and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice.

Kallassy J, Gagnon E, Rosenberg D, Silbart L, McManus S BMJ Open Diabetes Res Care. 2023; 11(3).

PMID: 37277225 PMC: 10254995. DOI: 10.1136/bmjdrc-2022-003101.


Adapting and Developing A Diabetes Prevention Intervention Programme for South Africa: Curriculum and Tools.

Hill J, Faber M, Peer N, George C, Oldenburg B, Kengne A Int J Environ Res Public Health. 2023; 20(5).

PMID: 36901472 PMC: 10002357. DOI: 10.3390/ijerph20054463.


References
1.
. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1985; 727:1-113. View

2.
Brenner B, Cooper M, de Zeeuw D, Keane W, Mitch W, Parving H . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345(12):861-9. DOI: 10.1056/NEJMoa011161. View

3.
Gillies C, Abrams K, Lambert P, Cooper N, Sutton A, Hsu R . Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007; 334(7588):299. PMC: 1796695. DOI: 10.1136/bmj.39063.689375.55. View

4.
Tuomilehto J, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344(18):1343-50. DOI: 10.1056/NEJM200105033441801. View

5.
Hernan W, Brandle M, Zhang P, Williamson D, Matulik M, Ratner R . Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2002; 26(1):36-47. PMC: 1402339. DOI: 10.2337/diacare.26.1.36. View